Hydrogels are promising candidates for the delivery of therapeutics in the treatment of
human cancers. Regarding to the biocomaptiiblity, high drug and encapsulation efficacy and …

Cancer, as leading cause of death, has a high rate of mortality worldwide. Although there is
a wide variety of conventional approaches for the treatment of cancer (such as surgery and …

Currently, cancer is the leading cause of death globally. In the absence of specific treatment
and early diagnosis, procedures like surgery, chemotherapy, and radiation therapy are often …

Nanotechnology has transformed the oncology sector by particularly targeting cancer cells
and enhancing the efficacy of conventional therapies, not only improving efficacy of …

Breast cancer is the most common malignancy among women and is the second leading
cause of cancer-related death for women. Depending on the tumor grade and stage, breast …

Simultaneous implementation of tumor-associated macrophage (TAM) repolarization and
immunogenic tumor cell death (ICD) elicitation enables tumor immunotherapy with high …

The convergence of nanotechnology and cancer therapeutics has opened new frontiers in
the development of advanced drug delivery systems. Among the various nanocarriers …

Gastrointestinal tumors are the main causes of death among the patients. These tumors are
mainly diagnosed in the advanced stages and their response to therapy is unfavorable. In …

Malignant ascites is a common complication of advanced cancers, which reduces survival
rates and diminishes patients' quality of life. Intraperitoneal chemotherapy is a conventional …

Cancer continues to be a leading factor in mortality and tackling it has been made difficult by
the development of immune escape. Furthermore, alternative treatments like surgery …